| |
| |
|
| Insider
Information: |
Peltz Stuart Walter |
| Relationship: |
Director |
| City: |
South Plainfield |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
189,223 |
|
|
Indirect Shares
|
54,903 |
|
|
| Direct
Value |
$6,275,095 |
|
|
|
Indirect Value
|
$2,005,058 |
|
|
| Total
Shares |
244,126 |
|
|
| Total
Value |
$8,280,153 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
23
|
|
Stock
price went up :
|
0
|
6
|
| Stock
price went down : |
0
|
17
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -511.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
PTC Therapeutics, Inc. |
PTCT |
|
2023-01-31 |
166,962 |
2023-01-31 |
54,903 |
Premium* |
|
|
Orchestra BioMed Holdings Inc. |
OBIO |
Director |
2020-08-03 |
22,261 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
77 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive OfficerOfficer |
• • – |
2013-06-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
188,803 |
|
- |
|
| OBIO |
Orchestra BioMed Holdings... |
Director |
– • – |
2020-08-03 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
22,261 |
|
- |
|
| OBIO |
Orchestra BioMed Holdings... |
Director |
– • – |
2020-08-03 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,261 |
|
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2017-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
21,600 |
28,876 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2019-01-22 |
4 |
A |
$0.00 |
$0 |
I/I |
4,620 |
22,158 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
33,000 |
56,085 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-01-29 |
4 |
A |
$0.00 |
$0 |
I/I |
4,855 |
22,957 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
I/I |
3,960 |
15,714 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
27,600 |
82,283 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-04-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,400 |
16,481 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2021-06-11 |
4 |
A |
$0.00 |
$0 |
I/I |
6,240 |
22,721 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
I/I |
16,800 |
39,340 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2022-01-07 |
4 |
A |
$0.00 |
$0 |
D/D |
44,000 |
122,446 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
I/I |
18,000 |
56,830 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
53,000 |
173,485 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-06-08 |
4 |
OE |
$10.85 |
$840,615 |
D/D |
77,476 |
77,476 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-06-09 |
4 |
OE |
$10.85 |
$285,355 |
D/D |
26,300 |
30,076 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2015-06-17 |
4 |
OE |
$10.85 |
$37,975 |
D/D |
3,500 |
7,276 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2019-12-03 |
4 |
OE |
$10.85 |
$265,169 |
I/I |
18,981 |
26,332 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-05 |
4 |
OE |
$10.85 |
$1,192,719 |
D/D |
109,928 |
166,013 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-18 |
4 |
OE |
$10.85 |
$68,181 |
D/D |
6,284 |
62,369 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-05-20 |
4 |
OE |
$10.85 |
$366,600 |
D/D |
33,788 |
89,873 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-07-15 |
4 |
OE |
$10.85 |
$1,085,000 |
D/D |
100,000 |
106,085 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-10-05 |
4 |
OE |
$10.85 |
$601,741 |
D/D |
55,460 |
110,645 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2020-10-06 |
4 |
OE |
$10.85 |
$1,368,902 |
D/D |
124,351 |
107,910 |
0 |
- |
|
77 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
